CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia
Article in Journal of Translational Medicine (March 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Journal of Translational Medicine (March 2024)
Article in Frontiers in Microbiology (August 2023)
Article in Immunology and Cell Biology (July 2022)